| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidyltransferase activity | 1.25e-08 | 6 | 109 | 4 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 1.25e-08 | 6 | 109 | 4 | GO:0002951 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 5.78e-08 | 8 | 109 | 4 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 1.04e-07 | 9 | 109 | 4 | GO:0036374 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 1.45e-06 | 16 | 109 | 4 | GO:0008242 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 3.81e-06 | 20 | 109 | 4 | GO:0070003 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.78e-04 | 231 | 109 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | IQSEC2 PLEKHG2 PREX2 ARHGEF15 EGF DENND4B DOCK6 RASAL1 AGAP2 NCKAP1L | 4.60e-04 | 507 | 109 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | IQSEC2 PLEKHG2 PREX2 ARHGEF15 EGF DENND4B DOCK6 RASAL1 AGAP2 NCKAP1L | 4.60e-04 | 507 | 109 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | extracellular matrix binding | 6.85e-04 | 73 | 109 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | nodal binding | 8.09e-04 | 8 | 109 | 2 | GO:0038100 | |
| GeneOntologyMolecularFunction | laminin binding | 8.37e-04 | 34 | 109 | 3 | GO:0043236 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 1.04e-03 | 9 | 109 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | molecular function activator activity | TOR1AIP2 EPO RELN SPP1 IL23A PREX2 SEMA4G ARHGEF15 LEFTY2 LEFTY1 EGF GUCA2B FAM20A RASAL1 AGAP2 NCKAP1L | 1.05e-03 | 1233 | 109 | 16 | GO:0140677 |
| GeneOntologyMolecularFunction | protein kinase activator activity | 1.36e-03 | 149 | 109 | 5 | GO:0030295 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 1.57e-03 | 11 | 109 | 2 | GO:0101020 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | VIL1 EPO IQSEC2 PLEKHG2 PREX2 ARHGEF15 GLMN EGF GUCA2B DENND4B DOCK6 FAM20A PIK3R5 RASAL1 PIF1 AGAP2 NCKAP1L | 1.72e-03 | 1418 | 109 | 17 | GO:0030234 |
| GeneOntologyMolecularFunction | kinase activator activity | 1.81e-03 | 159 | 109 | 5 | GO:0019209 | |
| GeneOntologyMolecularFunction | small GTPase binding | 1.91e-03 | 321 | 109 | 7 | GO:0031267 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 1.40e-07 | 10 | 107 | 4 | GO:1901750 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 2.20e-07 | 11 | 107 | 4 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 3.28e-07 | 12 | 107 | 4 | GO:1901748 | |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 3.11e-06 | 20 | 107 | 4 | GO:0006750 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 4.66e-06 | 22 | 107 | 4 | GO:0019184 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 4.66e-06 | 22 | 107 | 4 | GO:0019370 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 7.46e-06 | 8 | 107 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 7.89e-06 | 91 | 107 | 6 | GO:0033627 | |
| GeneOntologyBiologicalProcess | peptide modification | 1.59e-05 | 10 | 107 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | VIL1 CYP1B1 RELN MYO1C XBP1 ITGA6 IL23A SEMA4G DUOX1 EGF CPNE3 SNAI1 LRRC15 NCKAP1L | 2.30e-05 | 725 | 107 | 14 | GO:2000147 |
| GeneOntologyBiologicalProcess | icosanoid biosynthetic process | 2.56e-05 | 67 | 107 | 5 | GO:0046456 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal receptor complex assembly | 2.67e-05 | 2 | 107 | 2 | GO:1900124 | |
| GeneOntologyBiologicalProcess | regulation of nodal receptor complex assembly | 2.67e-05 | 2 | 107 | 2 | GO:1900123 | |
| GeneOntologyBiologicalProcess | nodal receptor complex assembly | 2.67e-05 | 2 | 107 | 2 | GO:0038099 | |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 2.82e-05 | 34 | 107 | 4 | GO:0043043 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | VIL1 CYP1B1 RELN MYO1C XBP1 ITGA6 IL23A SEMA4G DUOX1 EGF CPNE3 SNAI1 LRRC15 NCKAP1L | 2.96e-05 | 742 | 107 | 14 | GO:0040017 |
| GeneOntologyBiologicalProcess | modified amino acid catabolic process | 3.96e-05 | 37 | 107 | 4 | GO:0042219 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 5.98e-05 | 41 | 107 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | VIL1 CYP1B1 RELN MYO1C XBP1 ITGA6 IL23A SEMA4G EGF CPNE3 SNAI1 LRRC15 NCKAP1L | 6.00e-05 | 691 | 107 | 13 | GO:0030335 |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 7.24e-05 | 16 | 107 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 7.62e-05 | 84 | 107 | 5 | GO:0006518 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 9.78e-05 | 142 | 107 | 6 | GO:0006690 | |
| GeneOntologyBiologicalProcess | modified amino acid metabolic process | 1.43e-04 | 218 | 107 | 7 | GO:0006575 | |
| GeneOntologyBiologicalProcess | fatty acid derivative biosynthetic process | 1.53e-04 | 52 | 107 | 4 | GO:1901570 | |
| GeneOntologyBiologicalProcess | modified amino acid biosynthetic process | 1.53e-04 | 52 | 107 | 4 | GO:0042398 | |
| GeneOntologyBiologicalProcess | sulfur compound catabolic process | 1.65e-04 | 53 | 107 | 4 | GO:0044273 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 1.69e-04 | 21 | 107 | 3 | GO:0000097 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | CYP2C8 SPP1 XBP1 GGT2P GGT1 GGT3P GGT5 GOT1L1 CLCN2 OSBPL2 SNAI1 PCK1 | 2.01e-04 | 676 | 107 | 12 | GO:0044283 |
| GeneOntologyBiologicalProcess | cell differentiation involved in salivary gland development | 2.64e-04 | 5 | 107 | 2 | GO:0060689 | |
| GeneOntologyBiologicalProcess | cellular response to fructose stimulus | 2.64e-04 | 5 | 107 | 2 | GO:0071332 | |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 2.87e-04 | 25 | 107 | 3 | GO:0009070 | |
| GeneOntologyBiologicalProcess | glutathione metabolic process | 3.22e-04 | 63 | 107 | 4 | GO:0006749 | |
| GeneOntologyBiologicalProcess | sulfur compound biosynthetic process | 3.34e-04 | 178 | 107 | 6 | GO:0044272 | |
| GeneOntologyBiologicalProcess | regulation of bicellular tight junction assembly | 4.05e-04 | 28 | 107 | 3 | GO:2000810 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid biosynthetic process | 4.57e-04 | 69 | 107 | 4 | GO:0170038 | |
| GeneOntologyBiologicalProcess | L-amino acid biosynthetic process | 4.82e-04 | 70 | 107 | 4 | GO:0170034 | |
| GeneOntologyBiologicalProcess | neuron development | EPO RELN SPP1 L1CAM XBP1 ITGA6 PDZD7 FRYL PLXND1 ECE1 PREX2 NCDN SEMA4G CNTN6 SCYL2 TSKU RASAL1 NCKAP1L | 5.06e-04 | 1463 | 107 | 18 | GO:0048666 |
| GeneOntologyBiologicalProcess | negative regulation of nodal signaling pathway | 5.50e-04 | 7 | 107 | 2 | GO:1900108 | |
| GeneOntologyBiologicalProcess | alpha-amino acid biosynthetic process | 6.93e-04 | 77 | 107 | 4 | GO:1901607 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | CYP1B1 CYP2C8 XBP1 RNF213 CPT1B ECE1 GGT2P GGT1 GGT3P GGT5 DUOX1 VPS13D ZFYVE26 WDFY3 PCK1 GAA | 7.22e-04 | 1253 | 107 | 16 | GO:0044248 |
| GeneOntologyBiologicalProcess | hormone metabolic process | 7.33e-04 | 286 | 107 | 7 | GO:0042445 | |
| GeneOntologyBiologicalProcess | carboxylic acid biosynthetic process | 7.43e-04 | 374 | 107 | 8 | GO:0046394 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 7.69e-04 | 376 | 107 | 8 | GO:0008202 | |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | 7.82e-04 | 377 | 107 | 8 | GO:0016053 | |
| GeneOntologyBiologicalProcess | cellular response to corticosteroid stimulus | 8.38e-04 | 81 | 107 | 4 | GO:0071384 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 8.73e-04 | 580 | 107 | 10 | GO:0022407 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 8.77e-04 | 82 | 107 | 4 | GO:1901568 | |
| GeneOntologyBiologicalProcess | visceral serous pericardium development | 9.37e-04 | 9 | 107 | 2 | GO:0061032 | |
| GeneOntologyBiologicalProcess | regulation of nodal signaling pathway | 9.37e-04 | 9 | 107 | 2 | GO:1900107 | |
| GeneOntologyBiologicalProcess | positive regulation of memory T cell differentiation | 9.37e-04 | 9 | 107 | 2 | GO:0043382 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPO RELN SPP1 L1CAM ITGA6 PDZD7 FRYL PLXND1 ECE1 PREX2 NCDN SEMA4G CNTN6 TSKU RASAL1 NCKAP1L | 9.44e-04 | 1285 | 107 | 16 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 9.57e-04 | 389 | 107 | 8 | GO:0022409 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 9.68e-04 | 486 | 107 | 9 | GO:0007159 | |
| MousePheno | abnormal circulating glutathione level | 2.23e-06 | 5 | 86 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 2.23e-06 | 5 | 86 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 2.23e-06 | 5 | 86 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 2.23e-06 | 5 | 86 | 3 | MP:0012606 | |
| MousePheno | decreased circulating cysteine level | 7.73e-06 | 7 | 86 | 3 | MP:0030626 | |
| MousePheno | decreased cysteine level | 1.23e-05 | 8 | 86 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 1.23e-05 | 8 | 86 | 3 | MP:0004932 | |
| MousePheno | nervous | 1.84e-05 | 9 | 86 | 3 | MP:0008912 | |
| MousePheno | failure of copulatory plug deposition | 2.62e-05 | 10 | 86 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 2.62e-05 | 10 | 86 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 2.62e-05 | 10 | 86 | 3 | MP:0005158 | |
| MousePheno | abnormal circulating cysteine level | 3.58e-05 | 11 | 86 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 3.58e-05 | 11 | 86 | 3 | MP:0011130 | |
| MousePheno | abnormal left renal vein morphology | 3.74e-05 | 2 | 86 | 2 | MP:0011327 | |
| MousePheno | abnormal renal vein morphology | 3.74e-05 | 2 | 86 | 2 | MP:0011323 | |
| MousePheno | abnormal cysteine level | 6.15e-05 | 13 | 86 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 6.15e-05 | 13 | 86 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 6.15e-05 | 13 | 86 | 3 | MP:0012603 | |
| MousePheno | priapism | 7.79e-05 | 14 | 86 | 3 | MP:0003415 | |
| MousePheno | paralysis | 9.05e-05 | 119 | 86 | 6 | MP:0000753 | |
| MousePheno | abnormal kidney venous blood vessel morphology | 1.12e-04 | 3 | 86 | 2 | MP:0011311 | |
| MousePheno | abnormal copulatory plug deposition | 1.19e-04 | 16 | 86 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 1.19e-04 | 16 | 86 | 3 | MP:0008477 | |
| MousePheno | hindlimb paralysis | 1.24e-04 | 79 | 86 | 5 | MP:0000755 | |
| MousePheno | limb paralysis | 1.56e-04 | 83 | 86 | 5 | MP:0013147 | |
| MousePheno | failure of superovulation | 1.72e-04 | 18 | 86 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 1.72e-04 | 18 | 86 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 1.72e-04 | 18 | 86 | 3 | MP:0009093 | |
| MousePheno | increased circulating growth hormone level | 2.03e-04 | 19 | 86 | 3 | MP:0005123 | |
| MousePheno | abnormal copulation physiology | 2.03e-04 | 19 | 86 | 3 | MP:0031627 | |
| MousePheno | abnormal large intestine placement | 2.23e-04 | 4 | 86 | 2 | MP:0003284 | |
| MousePheno | abnormal sexual interaction | 2.80e-04 | 94 | 86 | 5 | MP:0002566 | |
| MousePheno | small vertebrae | 3.18e-04 | 22 | 86 | 3 | MP:0004610 | |
| MousePheno | increased growth hormone level | 3.64e-04 | 23 | 86 | 3 | MP:0005137 | |
| MousePheno | uterus hypoplasia | 3.64e-04 | 23 | 86 | 3 | MP:0001121 | |
| MousePheno | abnormal copulation behavior | 4.14e-04 | 24 | 86 | 3 | MP:0009697 | |
| MousePheno | right aortic arch | 5.01e-04 | 60 | 86 | 4 | MP:0004158 | |
| MousePheno | nuclear cataract | 5.28e-04 | 26 | 86 | 3 | MP:0010254 | |
| MousePheno | complete atrioventricular septal defect | 5.28e-04 | 26 | 86 | 3 | MP:0010413 | |
| MousePheno | absent heart right ventricle | 5.52e-04 | 6 | 86 | 2 | MP:0003872 | |
| MousePheno | abnormal long bone hypertrophic chondrocyte zone | 6.53e-04 | 113 | 86 | 5 | MP:0000165 | |
| MousePheno | decreased urine sodium level | 7.32e-04 | 29 | 86 | 3 | MP:0006317 | |
| MousePheno | aminoaciduria | 7.32e-04 | 29 | 86 | 3 | MP:0003311 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 8.06e-04 | 68 | 86 | 4 | MP:0003662 | |
| MousePheno | abnormal aortic arch morphology | 8.26e-04 | 119 | 86 | 5 | MP:0004113 | |
| MousePheno | abnormal cell motility | RELN SPP1 ITGA6 XPO4 PLXND1 GGT2P GGT1 GGT3P SNAI1 WDFY3 PIK3R5 DYNC1H1 VCAM1 NCKAP1L | 9.51e-04 | 885 | 86 | 14 | MP:0020846 |
| MousePheno | abnormal cell migration | RELN SPP1 ITGA6 PLXND1 SNAI1 WDFY3 PIK3R5 DYNC1H1 VCAM1 NCKAP1L | 9.84e-04 | 501 | 86 | 10 | MP:0003091 |
| MousePheno | left atrial isomerism | 1.02e-03 | 8 | 86 | 2 | MP:0008461 | |
| MousePheno | anovulation | 1.07e-03 | 33 | 86 | 3 | MP:0008869 | |
| MousePheno | abnormal cerebral hemisphere morphology | RELN SUSD4 IQSEC2 L1CAM ITGA6 XPO4 CNTN6 TSKU CLCN2 WDFY3 DYNC1H1 | 1.08e-03 | 599 | 86 | 11 | MP:0008540 |
| MousePheno | decreased circulating follicle stimulating hormone level | 1.17e-03 | 34 | 86 | 3 | MP:0002790 | |
| MousePheno | abnormal glial cell morphology | 1.26e-03 | 345 | 86 | 8 | MP:0003634 | |
| MousePheno | vascular ring | 1.28e-03 | 35 | 86 | 3 | MP:0010466 | |
| MousePheno | increased osteoclast cell number | 1.28e-03 | 77 | 86 | 4 | MP:0004984 | |
| MousePheno | accessory spleen | 1.31e-03 | 9 | 86 | 2 | MP:0003342 | |
| MousePheno | increased circulating interleukin-18 level | 1.31e-03 | 9 | 86 | 2 | MP:0008635 | |
| MousePheno | tricuspid valve atresia | 1.31e-03 | 9 | 86 | 2 | MP:0006123 | |
| MousePheno | abnormal telencephalon morphology | NDST1 RELN SUSD4 SPP1 IQSEC2 L1CAM ITGA6 XPO4 CNTN6 TSKU CLCN2 WDFY3 DYNC1H1 | 1.32e-03 | 812 | 86 | 13 | MP:0000787 |
| MousePheno | abnormal cardiac outflow tract development | 1.41e-03 | 134 | 86 | 5 | MP:0006126 | |
| MousePheno | abnormal thoracic aorta morphology | 1.41e-03 | 134 | 86 | 5 | MP:0010468 | |
| MousePheno | abnormal CNS glial cell morphology | 1.42e-03 | 272 | 86 | 7 | MP:0000952 | |
| Domain | GGT_peptidase | 6.12e-06 | 7 | 106 | 3 | IPR000101 | |
| Domain | G_GLU_TRANSPEPTIDASE | 6.12e-06 | 7 | 106 | 3 | PS00462 | |
| Domain | G_glu_transpept | 6.12e-06 | 7 | 106 | 3 | PF01019 | |
| Domain | LRDF | 3.19e-05 | 2 | 106 | 2 | IPR003942 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.38e-06 | 61 | 82 | 6 | MM14861 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 1.84e-06 | 16 | 82 | 4 | MM14680 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.23e-05 | 25 | 82 | 4 | MM14858 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 1.44e-05 | 26 | 82 | 4 | MM15190 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 1.69e-05 | 27 | 82 | 4 | MM15908 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 3.83e-05 | 33 | 82 | 4 | MM15963 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 4.85e-05 | 35 | 82 | 4 | MM15815 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 5.83e-05 | 170 | 82 | 7 | MM15573 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 6.75e-05 | 38 | 82 | 4 | MM14600 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 7.49e-05 | 39 | 82 | 4 | MM15695 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.51e-04 | 339 | 82 | 9 | M39736 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 2.70e-04 | 22 | 82 | 3 | MM15961 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 2.89e-04 | 55 | 82 | 4 | M39351 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 3.52e-04 | 24 | 82 | 3 | MM17249 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 3.79e-04 | 59 | 82 | 4 | M27140 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 3.79e-04 | 59 | 82 | 4 | M39886 | |
| Pathway | REACTOME_DRUG_ADME | 4.29e-04 | 109 | 82 | 5 | M45012 | |
| Pathway | KEGG_SELENOAMINO_ACID_METABOLISM | 4.48e-04 | 26 | 82 | 3 | M7151 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.83e-04 | 66 | 82 | 4 | M18 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 6.21e-04 | 29 | 82 | 3 | M45015 | |
| Pathway | REACTOME_DRUG_ADME | 6.40e-04 | 119 | 82 | 5 | MM15692 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 6.89e-04 | 7 | 82 | 2 | MM14856 | |
| Pathway | REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION | 6.89e-04 | 7 | 82 | 2 | M29845 | |
| Pathway | WP_FOCAL_ADHESION | 7.64e-04 | 187 | 82 | 6 | MM15913 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 9.15e-04 | 8 | 82 | 2 | M27135 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.05e-03 | 199 | 82 | 6 | M7253 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.17e-03 | 9 | 82 | 2 | M27143 | |
| Pubmed | 1.52e-09 | 6 | 112 | 4 | 11463821 | ||
| Pubmed | 1.52e-09 | 6 | 112 | 4 | 12163373 | ||
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 3.54e-09 | 7 | 112 | 4 | 1968405 | |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 3.25e-08 | 3 | 112 | 3 | 2573352 | |
| Pubmed | 9.95e-08 | 14 | 112 | 4 | 18357469 | ||
| Pubmed | Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. | 3.01e-07 | 18 | 112 | 4 | 17097888 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 23615310 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 11003618 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 10392451 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 3.24e-07 | 5 | 112 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 3.24e-07 | 5 | 112 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 3.24e-07 | 5 | 112 | 3 | 11089562 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 3.24e-07 | 5 | 112 | 3 | 12225953 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 7775425 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 9139708 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 3.24e-07 | 5 | 112 | 3 | 9546365 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 3.24e-07 | 5 | 112 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 3.24e-07 | 5 | 112 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 3.24e-07 | 5 | 112 | 3 | 24698228 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 10474818 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 3.24e-07 | 5 | 112 | 3 | 18063838 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 3.24e-07 | 5 | 112 | 3 | 11095909 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 7641802 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 9627710 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 12453183 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 2891746 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 3.24e-07 | 5 | 112 | 3 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 3.24e-07 | 5 | 112 | 3 | 8566783 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 30591459 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 11795900 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 3.24e-07 | 5 | 112 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 3.24e-07 | 5 | 112 | 3 | 19760322 | |
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 14634009 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 6.46e-07 | 6 | 112 | 3 | 8101000 | |
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 6.46e-07 | 6 | 112 | 3 | 8104871 | |
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 25326709 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 22242126 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 17363454 | ||
| Pubmed | 6.46e-07 | 6 | 112 | 3 | 8663190 | ||
| Pubmed | 6.71e-07 | 95 | 112 | 6 | 20843830 | ||
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 1.13e-06 | 7 | 112 | 3 | 32284594 | |
| Pubmed | 1.13e-06 | 7 | 112 | 3 | 36685533 | ||
| Pubmed | 1.13e-06 | 7 | 112 | 3 | 27775020 | ||
| Pubmed | 1.69e-06 | 27 | 112 | 4 | 18478268 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MYO1C SPP1 IL18BP AQP2 PABPC1 GGT2P GGT1 GGT3P EGF GUCA2B CPNE3 DYNC1H1 GAA VCAM1 LRRC15 | 1.84e-06 | 1070 | 112 | 15 | 23533145 |
| Pubmed | 3.84e-06 | 10 | 112 | 3 | 23863468 | ||
| Pubmed | 5.26e-06 | 11 | 112 | 3 | 27297885 | ||
| Pubmed | 9.08e-06 | 13 | 112 | 3 | 34679163 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 25180444 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 38566328 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 32745796 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 25280941 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 20056823 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 10053005 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 25280803 | ||
| Pubmed | Mutation analysis of human LEFTY A and LEFTY B genes in children with Ivemark syndrome. | 1.03e-05 | 2 | 112 | 2 | 11100524 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 27436590 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 24147624 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 25377544 | ||
| Pubmed | Lefty antagonises TGF-beta1 induced epithelial-mesenchymal transition in tubular epithelial cells. | 1.03e-05 | 2 | 112 | 2 | 20171171 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 9496783 | ||
| Pubmed | A functional role of LEFTY during progesterone therapy for endometrial carcinoma. | 1.03e-05 | 2 | 112 | 2 | 29268772 | |
| Pubmed | Gamma-glutamyl compounds: substrate specificity of gamma-glutamyl transpeptidase enzymes. | 1.03e-05 | 2 | 112 | 2 | 21447318 | |
| Pubmed | Lefty1 Ameliorates Post-infarction Fibrosis by Suppressing p-Smad2 and p-ERK1/2 Signaling Pathways. | 1.03e-05 | 2 | 112 | 2 | 33409963 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 29230527 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 24045955 | ||
| Pubmed | Molecular analysis of LEFTY-expressing cells in early human embryoid bodies. | 1.03e-05 | 2 | 112 | 2 | 17038673 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 37904480 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 29286065 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 23682772 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 19604397 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 8253814 | ||
| Pubmed | Isolation, characterization, and function of EBAF/LEFTY B: role in infertility. | 1.03e-05 | 2 | 112 | 2 | 21401636 | |
| Pubmed | Lefty is expressed in mouse endometrium in estrous cycle and peri-implantation period. | 1.03e-05 | 2 | 112 | 2 | 15640253 | |
| Pubmed | 1.44e-05 | 15 | 112 | 3 | 15366018 | ||
| Pubmed | 1.44e-05 | 15 | 112 | 3 | 12361961 | ||
| Pubmed | 2.56e-05 | 18 | 112 | 3 | 16801545 | ||
| Pubmed | 2.56e-05 | 18 | 112 | 3 | 22912414 | ||
| Pubmed | 2.60e-05 | 179 | 112 | 6 | 19074885 | ||
| Pubmed | 3.03e-05 | 19 | 112 | 3 | 16950123 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 27829223 | ||
| Pubmed | Nodal and lefty signaling regulates the growth of pancreatic cells. | 3.08e-05 | 3 | 112 | 2 | 18393305 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 32065356 | ||
| Pubmed | Role of asymmetric signals in left-right patterning in the mouse. | 3.08e-05 | 3 | 112 | 2 | 11471154 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 16141390 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 25722189 | ||
| Pubmed | Distinct transcriptional regulation and phylogenetic divergence of human LEFTY genes. | 3.08e-05 | 3 | 112 | 2 | 10886363 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 7669058 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 37097539 | ||
| Pubmed | Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells. | 3.08e-05 | 3 | 112 | 2 | 26316705 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 9763436 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 24203464 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 26507668 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 17011489 | ||
| Interaction | GGTLC1 interactions | 8.45e-06 | 8 | 109 | 3 | int:GGTLC1 | |
| Interaction | GGT1 interactions | 9.38e-06 | 25 | 109 | 4 | int:GGT1 | |
| Interaction | SFTPC interactions | 2.80e-05 | 222 | 109 | 8 | int:SFTPC | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 1.28e-07 | 13 | 68 | 4 | 564 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.97e-03 | 66 | 68 | 3 | 722 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.05e-03 | 18 | 68 | 2 | 1160 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 3.72e-07 | 108 | 110 | 7 | MM1334 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.44e-05 | 103 | 108 | 6 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k3 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_NA_vs_Mesoderm Day 5-reprogram_OSKM - NLT-Confounder_removed-fold2.0_adjp0.05 | 2.51e-05 | 68 | 108 | 5 | PCBC_ratio_MESO-5_from-ESC_vs_MESO-5_from-OSKM - NLT_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-5 blastocyst_vs_MESO-5 UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 2.74e-05 | 171 | 108 | 7 | PCBC_ratio_MESO-5 blastocyst_vs_MESO-5 UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_NA_vs_Mesoderm Day 5-method_episomal-Confounder_removed-fold2.0_adjp0.05 | 8.03e-05 | 45 | 108 | 4 | PCBC_ratio_MESO-5_from-ESC_vs_MESO-5_from-episomal_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_top-relative-expression-ranked_1000 | SPP1 AOAH SYTL2 ECE1 PREX2 ARHGEF15 GGT1 VPS13D EGF GUCA2B CRYBG3 DOCK6 PCK1 VCAM1 | 9.86e-05 | 846 | 108 | 14 | gudmap_kidney_adult_CortVasc_Tie2_1000 |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-08 | 108 | 112 | 7 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.30e-07 | 184 | 112 | 7 | 7e1a2971321ddcfa00d78d3e3ba7960e532f9392 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-07 | 189 | 112 | 7 | 8ced0381ea042ba47680a02b617a2368fa2c54c8 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-07 | 189 | 112 | 7 | 403a82bb416aed13b9d31411ad17bdc4ce2a95fb | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-07 | 190 | 112 | 7 | 68ba1934b2b3f0cec8efd229fe1db6e8be8a26b0 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-07 | 190 | 112 | 7 | 010d7d13a3c16e614c36720ef690a505b9f3f7aa | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 6.15e-07 | 194 | 112 | 7 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | Fetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.58e-07 | 196 | 112 | 7 | 3981f6c7487598f4f7ce4650ac0ac5bd41481d66 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.69e-06 | 155 | 112 | 6 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.69e-06 | 155 | 112 | 6 | 0f24ef6486aef354f0911c06932cb01d1a0525ac | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.69e-06 | 155 | 112 | 6 | d8b5145258f075b15080f8739f537f48dd22225e | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.11e-06 | 159 | 112 | 6 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.73e-06 | 171 | 112 | 6 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.73e-06 | 171 | 112 | 6 | e219a1aa59a96e4bc3e2eacf985679174a51de41 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 175 | 112 | 6 | c36b4526970db9ccfbe2c70b00961fab9f13b133 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 175 | 112 | 6 | c1e082538f31b5c98ac63f71dcca4a1211a14708 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 175 | 112 | 6 | 2f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.58e-06 | 176 | 112 | 6 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-06 | 180 | 112 | 6 | bb2dbf7ed03d5ac765635b7afe738efa822841d0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-06 | 180 | 112 | 6 | c62417f205bcbf3b212ae177f63562ec6467c855 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-06 | 181 | 112 | 6 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.20e-06 | 184 | 112 | 6 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 7.43e-06 | 185 | 112 | 6 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.43e-06 | 185 | 112 | 6 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-06 | 185 | 112 | 6 | a6874dd3030d04380cc3c01de1069461aad4ef45 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-06 | 186 | 112 | 6 | d4e327cc1d7b618654ffe0ff6475fe8e8cc5cb01 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 7.90e-06 | 187 | 112 | 6 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.90e-06 | 187 | 112 | 6 | 7170694a1b86fe8d84d96c880ffe57af09bdc026 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 188 | 112 | 6 | 05de6677f9bb4b00fed47f4b72f4a2cd507cb0f2 | |
| ToppCell | (0)_NK/T_cells-(0)_T_CD8|(0)_NK/T_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.31e-06 | 109 | 112 | 5 | 73b188278473a3b112d406657680267b17a5b712 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.39e-06 | 189 | 112 | 6 | a438c64a893d43f781ede42e1c7b615b74dc76ef | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-06 | 190 | 112 | 6 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | (2)_5-FU-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 8.65e-06 | 190 | 112 | 6 | 6b391b8a3ffcbdec3acaf242bc52fc3fc9da77c8 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.65e-06 | 190 | 112 | 6 | 081b7bc07b6e5685e8a91b9ae6c1141623723700 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.65e-06 | 190 | 112 | 6 | 773c55b9e28c2f77a5eb5f0adb0fa9862fb9611d | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.65e-06 | 190 | 112 | 6 | 912aa106581d1ed7e147c92f9a367e8e6b04052b | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.91e-06 | 191 | 112 | 6 | adb2e3efcad02889d8229325080da5e7830fd3ae | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.91e-06 | 191 | 112 | 6 | bce138f067b8962ecef1ddec6511a3f142d81d78 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-06 | 192 | 112 | 6 | 945153c41dde6e90d103206955e1707b54eb0665 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.18e-06 | 192 | 112 | 6 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-06 | 192 | 112 | 6 | 6ab50579c63f31ca2cd41063a99b129f11c07510 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.18e-06 | 192 | 112 | 6 | 4e3deefd30adb7bf1eba294610eed3d077aa9418 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.46e-06 | 193 | 112 | 6 | 2684fa361baaa9dc7a18a39ed11c0759e78e4418 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-NKT1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.46e-06 | 193 | 112 | 6 | 52f42ec293a5077a44de5c27e89b57c23944e560 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.48e-06 | 112 | 112 | 5 | 153614f307525af56501ac8f9c357c5f7de7882c | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.48e-06 | 112 | 112 | 5 | ba0bd3a77c4865a71fb92d195cd7459c562b63db | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.48e-06 | 112 | 112 | 5 | f9a796b4b5e227096ab360ca9ec08b1c564ac1eb | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.74e-06 | 194 | 112 | 6 | 846b4170544cdf58b536fb7a5fd34b79b0b17993 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.74e-06 | 194 | 112 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.74e-06 | 194 | 112 | 6 | 260649f5c4aeaa9cbf5ed5ae5e9f293d75bb0457 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 195 | 112 | 6 | 4db30b3bc65c25626f828cd4f867f20c71809898 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.00e-05 | 195 | 112 | 6 | 518cc3baeb7cf2ad068692cbe85fd75be67f1872 | |
| ToppCell | Endothelial|World / shred by cell class for bronchial biopsy | 1.00e-05 | 195 | 112 | 6 | f0e46e859f7a9bdead3203889f7e20fa21f76ff0 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 1.03e-05 | 196 | 112 | 6 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-05 | 197 | 112 | 6 | b803c07072a7860497d07a3be358a28a24359cbf | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 197 | 112 | 6 | 78bc83cd5546c7dd128e6791acda97f55089bc1c | |
| ToppCell | COVID-19|World / Condition, Lineage and Cell class | 1.06e-05 | 197 | 112 | 6 | 228f641d79282cc3dc51b95a1f4b0cccfc200735 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 197 | 112 | 6 | 15d1e0dffee8f5ba8cee37adfbfa0551a0cd5e15 | |
| ToppCell | wk_15-18-Endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 198 | 112 | 6 | dcf453e22dba90c0ae349fa6c3d4c20758bb95af | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | d359f3e1595ba8d8a3dc9eb2e8f2b61f3247c7a1 | |
| ToppCell | background-Kupffer_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.13e-05 | 199 | 112 | 6 | 91d229f3515d49639bcb5505e6aec4a9abade81c | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | e2d5c5cab102e67b0131b02392d81adaedc15965 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-05 | 199 | 112 | 6 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-05 | 199 | 112 | 6 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | 54b64f01e7a73a88bd92b6d4e73cccde60396b2d | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 200 | 112 | 6 | 88d713dfc792e7609bf7ecfb28f87cb748088570 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-BMP_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-05 | 200 | 112 | 6 | 01d707c4f8ee0daac635b7260937b1baebc6fc23 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 200 | 112 | 6 | 2cca77b2c9d829daa674a844e068f2b083e90d6e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 200 | 112 | 6 | 86ec951234015ced7126b016199e5869a0f22478 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-05 | 200 | 112 | 6 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.16e-05 | 200 | 112 | 6 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-05 | 200 | 112 | 6 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.10e-05 | 132 | 112 | 5 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.98e-05 | 142 | 112 | 5 | f4e4cde228149d5a536fbf0517ed71d81e296faf | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.26e-05 | 153 | 112 | 5 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.26e-05 | 153 | 112 | 5 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.26e-05 | 153 | 112 | 5 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.40e-05 | 154 | 112 | 5 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.40e-05 | 154 | 112 | 5 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.40e-05 | 154 | 112 | 5 | b5604c0b0b9b283352a3f612f40883b9123475d1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.40e-05 | 154 | 112 | 5 | 160b170a3ade8b246843c9854af332475c047ba0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 155 | 112 | 5 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | Goblet|World / Class top | 4.82e-05 | 157 | 112 | 5 | b352aa37d662629db6a9c6def9ee6d7c49a9071c | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Cytotoxic_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.12e-05 | 159 | 112 | 5 | 2060e7ed5627976b48fea4a2328762b6fa308db1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 160 | 112 | 5 | 939e25ef8b64242da2d28ef8342c8eb9cd199f17 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.65e-05 | 168 | 112 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | facs-Kidney|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-05 | 168 | 112 | 5 | d2f17a470e04f8f0edb111894027bcfc6ee1a12f | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.83e-05 | 169 | 112 | 5 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 169 | 112 | 5 | 630d921aa8fb5681d06a4e09b833855c374be484 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 169 | 112 | 5 | 468284d4a3a0557aed04eadb1aba2317babc6904 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 169 | 112 | 5 | 6f765e142d127545e622fe24b5287cd6e9706ccc | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-05 | 171 | 112 | 5 | 2e7cc311005958af52f39ca6c310c85b43a85aaf | |
| Drug | CAS 76095-16-4 | 1.80e-07 | 126 | 110 | 8 | CID000003222 | |
| Drug | H526 | 4.35e-06 | 192 | 110 | 8 | CID000002550 | |
| Drug | Glutathione | 6.05e-06 | 340 | 110 | 10 | ctd:D005978 | |
| Drug | gallin | 6.89e-06 | 55 | 110 | 5 | CID000191336 | |
| Drug | CARMINE | 9.66e-06 | 28 | 110 | 4 | CID000014749 | |
| Drug | AC1L1K7T | VIL1 CYP1B1 CYP2C8 UGT1A6 XBP1 XRCC3 LEFTY2 LEFTY1 CLCN2 OSBPL2 EGF PIK3R5 PKN3 | 1.16e-05 | 632 | 110 | 13 | CID000005376 |
| Drug | Sirolimus | 1.32e-05 | 456 | 110 | 11 | ctd:D020123 | |
| Drug | losartan | 1.52e-05 | 378 | 110 | 10 | CID000003961 | |
| Drug | creatinine | 1.62e-05 | 302 | 110 | 9 | CID000000588 | |
| Drug | Indican | 1.67e-05 | 32 | 110 | 4 | ctd:D007200 | |
| Drug | nafenopin | 2.43e-05 | 71 | 110 | 5 | CID000019592 | |
| Drug | Mometasone Furoate | 3.03e-05 | 13 | 110 | 3 | ctd:D000068656 | |
| Drug | N-benzylformamide | 3.38e-05 | 76 | 110 | 5 | CID000080654 | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 3.64e-05 | 188 | 110 | 7 | 6195_DN | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 3.76e-05 | 189 | 110 | 7 | CID000001413 | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 4.30e-05 | 193 | 110 | 7 | 5919_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.59e-05 | 195 | 110 | 7 | 6979_DN | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; HL60; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 2476_DN | |
| Drug | Nicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 2058_DN | |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; PC3; HG-U133A | 5.05e-05 | 198 | 110 | 7 | 1897_UP | |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; HL60; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 2170_UP | |
| Drug | Isoconazole [27523-40-6]; Up 200; 9.6uM; PC3; HT_HG-U133A | 5.22e-05 | 199 | 110 | 7 | 5857_UP | |
| Drug | aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 2664_DN | |
| Drug | phenobarbital | 6.38e-05 | 360 | 110 | 9 | CID000004763 | |
| Drug | angiotensin | 6.90e-05 | 282 | 110 | 8 | CID003083715 | |
| Drug | 2-nor-LTD1 | 6.92e-05 | 3 | 110 | 2 | CID006439851 | |
| Drug | dulofibrate | 6.92e-05 | 3 | 110 | 2 | CID000068812 | |
| Drug | 2-(glutathion-S-yl)hydroquinone | 6.92e-05 | 3 | 110 | 2 | CID000177871 | |
| Drug | Glu-AMC | 6.92e-05 | 3 | 110 | 2 | CID000126296 | |
| Drug | gamma-glutamyl-3-carboxy-4-nitroanilide | 6.92e-05 | 3 | 110 | 2 | CID000104545 | |
| Drug | 2-bromo-3-(N-acetylcystein-S-yl)hydroquinone | 6.92e-05 | 3 | 110 | 2 | CID000130861 | |
| Drug | CYSSG | 7.10e-05 | 17 | 110 | 3 | CID003080690 | |
| Drug | diclofenac | 7.11e-05 | 209 | 110 | 7 | CID000003032 | |
| Drug | SR121463 | 1.00e-04 | 19 | 110 | 3 | CID000158348 | |
| Drug | Acetylcysteine | GPBAR1 CYP1B1 SPP1 UGT1A6 XBP1 XRCC3 CPT1B AQP2 GGT1 EGF SNAI1 PCK1 VCAM1 | 1.01e-04 | 780 | 110 | 13 | ctd:D000111 |
| Drug | vasopressin | 1.13e-04 | 388 | 110 | 9 | CID011979316 | |
| Drug | AC1Q6PCP | 1.29e-04 | 230 | 110 | 7 | CID000005267 | |
| Drug | candesartan | 1.38e-04 | 162 | 110 | 6 | CID000002541 | |
| Drug | Agaridoxin | 1.38e-04 | 4 | 110 | 2 | CID000162851 | |
| Drug | formylcolchicine | 1.38e-04 | 4 | 110 | 2 | CID000630944 | |
| Drug | 2-propyltoluene | 1.38e-04 | 4 | 110 | 2 | CID000014091 | |
| Drug | AC1L41R0 | 1.38e-04 | 4 | 110 | 2 | CID000175821 | |
| Drug | leukotriene C3 | 1.38e-04 | 4 | 110 | 2 | CID005214901 | |
| Drug | AC1MLYZ1 | 1.38e-04 | 4 | 110 | 2 | CID003277748 | |
| Drug | biotinamidocaproyl hydrazide | 1.38e-04 | 4 | 110 | 2 | CID000083900 | |
| Drug | beta-aminoglutaryl-L-alpha-aminobutyrate | 1.38e-04 | 4 | 110 | 2 | CID000191734 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 1.52e-06 | 7 | 105 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 2.42e-06 | 8 | 105 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | Kidney Diseases | 1.61e-05 | 88 | 105 | 5 | C0022658 | |
| Disease | Uremia | 2.87e-05 | 17 | 105 | 3 | C0041948 | |
| Disease | pancreatitis (is_marker_for) | 1.25e-04 | 5 | 105 | 2 | DOID:4989 (is_marker_for) | |
| Disease | diabetic neuropathy (is_marker_for) | 3.46e-04 | 8 | 105 | 2 | DOID:9743 (is_marker_for) | |
| Disease | anemia (is_marker_for) | 5.54e-04 | 10 | 105 | 2 | DOID:2355 (is_marker_for) | |
| Disease | diabetic retinopathy (is_marker_for) | 9.52e-04 | 54 | 105 | 3 | DOID:8947 (is_marker_for) | |
| Disease | Malformations of Cortical Development | 1.11e-03 | 14 | 105 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 1.11e-03 | 14 | 105 | 2 | C0431380 | |
| Disease | Dermatitis | 1.46e-03 | 16 | 105 | 2 | C0011603 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.49e-03 | 63 | 105 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | CYP1B1 SPP1 SMARCAL1 XBP1 XRCC3 PABPC1 CNTN6 EGF ZFYVE26 SNAI1 AGAP2 | 1.55e-03 | 1074 | 105 | 11 | C0006142 |
| Disease | lupus nephritis (is_marker_for) | 1.65e-03 | 17 | 105 | 2 | DOID:0080162 (is_marker_for) | |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 1.65e-03 | 17 | 105 | 2 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | glomerulonephritis (implicated_via_orthology) | 1.65e-03 | 17 | 105 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | Gastric ulcer | 1.85e-03 | 18 | 105 | 2 | C0038358 | |
| Disease | Malignant Glioma | 2.02e-03 | 70 | 105 | 3 | C0555198 | |
| Disease | mixed gliomas | 2.02e-03 | 70 | 105 | 3 | C0259783 | |
| Disease | bipolar disorder (is_marker_for) | 2.06e-03 | 19 | 105 | 2 | DOID:3312 (is_marker_for) | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 2.06e-03 | 19 | 105 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | lymphocyte count | EPO PCDHGA3 XBP1 RIPOR3 PLXND1 PREX2 ARHGEF15 GGT5 GLMN OSBPL2 EGF PRF1 VCAM1 | 2.09e-03 | 1464 | 105 | 13 | EFO_0004587 |
| Disease | Arthrogryposis | 2.52e-03 | 21 | 105 | 2 | C0003886 | |
| Disease | epilepsy (implicated_via_orthology) | 2.78e-03 | 163 | 105 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | liver cirrhosis (is_marker_for) | 3.16e-03 | 82 | 105 | 3 | DOID:5082 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALNWPQALPSVLQIA | 31 | P41181 | |
| RLSLNASLPAPWQAV | 846 | Q9P2K9 | |
| AAPPALRRNLLLQAW | 246 | A8MXV6 | |
| RQILLRPNEIPNWTA | 2806 | Q68DQ2 | |
| LAQALWLNPPNTGAR | 281 | Q8NHS2 | |
| RILNSPWIQVCNNFP | 206 | P10632 | |
| NLNPVWRPFKISLNS | 186 | O75131 | |
| APNPTWASLNLGALI | 951 | Q99490 | |
| PRNTLWQELPAVQAS | 391 | O94989 | |
| TLPTGQLSNIPWRRA | 156 | Q9Y2T2 | |
| DLNRQWLSPSAHLQP | 861 | Q96MI9 | |
| NQWLSALRKASAPNP | 661 | O95294 | |
| ATWLNPDPSQKQNLL | 41 | P10451 | |
| LVNNWPCNPELTLIA | 206 | P35558 | |
| KLFSLPAQPLWNNRL | 371 | O60216 | |
| PAQPLWNNRLLKLFT | 376 | O60216 | |
| SQIAQLRPSPRWTAQ | 426 | P11940 | |
| SQPWQAALLVQGRLL | 46 | Q9UKR3 | |
| INLPTALTNELDWPQ | 286 | P28039 | |
| ALGLSPITRWQDINP | 441 | Q9NRD9 | |
| LPWARLFQPSIQLAR | 151 | A6NGU5 | |
| NPANRSLVLPWSFPL | 56 | Q9H496 | |
| SLGLLQIQTWLPQAR | 3226 | Q9NU22 | |
| FWQQLSRPRQPLLLQ | 186 | O75610 | |
| PAALRSRWPQELLQL | 656 | Q9UBB6 | |
| LALPTLPGLWNQSRR | 66 | Q8TDU6 | |
| RPALWTQPLTSQQLQ | 81 | Q9Y5R4 | |
| AQLWAGLRATLPPTQ | 166 | O95998 | |
| PWAQRARLQPASVAL | 291 | Q5JU85 | |
| LQPLSSNTPIWACRL | 196 | Q8N187 | |
| SLPLRFWVNILKNPQ | 1766 | Q9Y4D7 | |
| LWQAALSTLNPNPTD | 51 | Q8NDH3 | |
| WLDRLSNGVLQQLSP | 306 | Q9H5P4 | |
| QEGTLQRLPLALTNW | 81 | P14222 | |
| QRLPLALTNWRAQGS | 86 | P14222 | |
| NALVPVSWKRPQLSQ | 2341 | O94915 | |
| QWRSAQLLSLISNPP | 221 | P55160 | |
| HSWTNLRLQTLPPVQ | 551 | P52848 | |
| NTSLLLRWQPPLSHN | 931 | P32004 | |
| PLTNLGTATLNIQWP | 881 | P23229 | |
| GWNRITIPLPNAALT | 631 | P78509 | |
| LLQQAPPNTDWRFSQ | 806 | Q9Y5H0 | |
| APNWTGLQTLLQQLP | 21 | Q2TBC4 | |
| ILASERALPWQLNDP | 111 | Q6PI98 | |
| PALLQRWATDLTLPQ | 1266 | Q96HP0 | |
| LSANPLWQQRALDPP | 1186 | P01133 | |
| TALLQAQKWPFQPSR | 11 | Q6P2I3 | |
| WAPSPRLQAQSLLPA | 51 | Q16661 | |
| QIPSLSPSQPWQRLL | 146 | Q9NPF7 | |
| TAFTQQRLPAWQPLL | 16 | Q3MIR4 | |
| QRLPAWQPLLSASIA | 21 | Q3MIR4 | |
| ALLVNSSQPWEPLQL | 106 | P01588 | |
| RLPWAQLFQPTIALL | 156 | P36269 | |
| LSWRAGPDNNSPIQI | 616 | Q9UQ52 | |
| FWQQLSRPRQPLLLQ | 186 | O00292 | |
| ITLWNRDLAPTPGAN | 276 | P10253 | |
| DRPLALPLSDSQIQW | 121 | Q8NDX9 | |
| QVRLLWDVLTPDPNS | 1346 | O75064 | |
| QTPSWLGLPNNAERV | 4316 | Q14204 | |
| WPLNPLSIQQTTLLL | 11 | Q16678 | |
| PQSWLLVGAPQALAL | 66 | Q13683 | |
| AAELQTLAPAINWLP | 336 | P42892 | |
| GSILLQSCQLPPQWL | 121 | P51172 | |
| NSRRWCSNLTPNVPN | 146 | Q8IXA5 | |
| RRLQAWPQSEAPLSV | 11 | Q9BWJ2 | |
| PWRLSTSQIPQSQIR | 681 | Q92523 | |
| LPWARLFQPSIQLAR | 151 | P36268 | |
| TNWQALLARTIQPPF | 821 | Q6P5Z2 | |
| ALSTLWNQLSLLPVP | 146 | Q92990 | |
| IQNIPPWTTRLSSNL | 601 | Q5TD94 | |
| GQLLSRQQLPLQLAW | 536 | Q9H611 | |
| VNSPNTWIEATLPLR | 911 | Q9HCH5 | |
| WSRQLPNGELQPLSE | 546 | P19320 | |
| TPNWFLNLSAPILNI | 166 | Q96HV5 | |
| FILSPRSLLQENNWP | 141 | Q96CG3 | |
| NWLLLNQPRLGTDTV | 436 | Q8TF66 | |
| WRDALTLPEAQPQNS | 31 | Q15572 | |
| SLNLAPRLSVPNPWI | 346 | Q96MK3 | |
| AQSLPTVNLQPLEWA | 291 | Q9NZC9 | |
| VPWIALNLSHNPRTL | 21 | Q8NE22 | |
| LANVLGNWENLPSPI | 126 | Q6P3W7 | |
| VQAQLSPLQNISPWI | 176 | P17861 | |
| RAWSVLPDNFLQLPL | 326 | A6NEL2 | |
| AQILVLWSNERPLPS | 446 | Q92935 | |
| KLLWRINTRPPNSAQ | 361 | Q9H1P3 | |
| SQAWNPPRANVFLTL | 421 | P51788 | |
| QFSPQSLQRWLILPC | 6 | Q8N4M7 | |
| RASQDPQLLAWLPDQ | 41 | Q8N4M7 | |
| PQLLAWLPDQSLEVS | 46 | Q8N4M7 | |
| TRNTLKPSPQAWLQL | 3871 | Q63HN8 | |
| LFINLCQWTRIPAPQ | 66 | Q8WWB5 | |
| PAAFSALPRWKQQNL | 806 | P09327 | |
| APQAQPIAWASLRLQ | 66 | O95863 | |
| NQVLSWNFLPPNLGR | 231 | Q9C0E2 | |
| TPPAQRQIASLVWRL | 1251 | Q8IZQ1 | |
| SEAWLAPQAPRNLPQ | 176 | Q9NX65 | |
| QPSNLARALWLLNGS | 586 | Q9NTN9 | |
| TQLPSWLLAPASRPQ | 486 | Q8WYR1 | |
| LGQLQPLPQTLRAWA | 811 | Q96MK2 | |
| PLPQTLRAWALLQLD | 816 | Q96MK2 | |
| NLRTSLWQQRPELSP | 171 | Q7Z6J8 | |
| QNLIWSSSPPRCLAL | 226 | Q5VX71 | |
| TLWDLAPTPQVRAQL | 231 | A0A1W2PR48 | |
| LWKNLQDPSNPAIIR | 11 | Q2M238 | |
| DPWNLPSSVRTLAQN | 1221 | Q70Z35 | |
| QLQLPEWLSRPAASL | 496 | Q9Y6S9 | |
| LLIWAQGLRQAPLAS | 6 | Q495A1 | |
| VFWNLPTNSPLQRIR | 581 | Q8WUA4 | |
| LSLSPPAALWLQERQ | 206 | Q9H7P9 | |
| LLPAAPQEQWRQLDS | 216 | P17022 | |
| PSNLANNTILVKWLP | 341 | P19224 | |
| QPPATLSWVLQNRVL | 281 | Q96LC7 | |
| LPAPTIQSLNLAWNR | 181 | Q8WUA8 | |
| VLWDLLRQSPQPAQA | 156 | Q68DK2 | |
| SPALGITWANQLLVR | 281 | O43542 | |
| LQLQQTPPLQLRWDR | 256 | A6NL46 | |
| WRPLQAQNLPSSGPL | 221 | Q6ZQT7 | |
| SWQQQAASRLHPPRL | 2776 | Q5THJ4 | |
| LPWARLFQPSIQLAR | 151 | P19440 | |
| RRQLPQNVLDTSWPT | 821 | O00159 |